Wells Fargo Upgrades Five Prime Therapeutics (FPRX) to Overweight

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. GOOGL
3. MSFT
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Wells Fargo Upgrades Five Prime Therapeutics (FPRX) to Overweight

Five Prime Therapeutics (FPRX) Announces Proposed 5M Share Common Offering

November 11, 2020 4:05 PM EST

Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, announced today that it plans to offer and sell, subject to market and other conditions, 5,000,000 shares of its common stock in an... More

Five Prime Therapeutics (FPRX) Halted on LUDP

November 11, 2020 9:48 AM EST

Five Prime Therapeutics (NASDAQ: FPRX) Halted on LUDP

... More